IFP Advisors’s OnKure Therapeutics OKUR Stock Holding History

IFP Advisors’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$49	Buy	+18	New	+$68	﹤0.01%	5065

Other funds holding OKUR

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

IFP Advisors's OKUR Position: Q3 2026 in Review

IFP Advisors opened a new position in OnKure Therapeutics (OKUR) in Q3 2026: 18 shares worth $49. The stake represents ﹤0.01% of the portfolio and ranks #5065 among its holdings.

12 funds tracked by Wall St. Rank hold OKUR as of Q3 2026.

IFP Advisors held 18 shares of OnKure Therapeutics worth $49 as of Q3 2026.
OnKure Therapeutics was a new IFP Advisors position in Q3 2026.
OnKure Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #5065 holding.
12 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.